Summary of disease control, spirometry and airway inflammation before and 1 year after the start of biologics at the Pediatric Asthma Center
Disease control and instrumental data | Case 1 | Case 2 | Case 3 | Case 4 | ||||
---|---|---|---|---|---|---|---|---|
Pre | Post | Pre | Post | Pre | Post | Pre | Post | |
C-ACT | 8 | 23 | 16 | 20 | 13 | 20 | 10 | 22 |
Asthma attacks/year | 8 | 2 | 12 | 6 | 9 | 2 | 10 | 3 |
FEV1 (%pred) | 61 | 82 | 85 | 90 | 89 | 111 | 67 | 75 |
FVC (%pred) | 88 | 100 | 104 | 104 | 111 | 132 | 117 | 97 |
FEV1/FVC (%) | 69 | 81 | 81 | 86 | 80 | 84 | 57 | 77 |
FEF25–75 (%pred) | 71 | 96 | 66 | 80 | 73 | 89 | 25 | 82 |
FeNO (ppb) | 38 | 14 | 53 | 14 | 120 | 42 | 24 | 17 |
C-ACT: childhood asthma control test; FEV1: forced expiratory volume during the first second; FVC: forced vital capacity; FEF25–75: forced mid-expiratory flow; FeNO: fractional exhaled nitric oxide